Posts With Tag NASDAQ CERO

Discover vital updates from Cero Therapeutics Holdings, Inc. in their February 12, 2025, 8-K report on common stock and warrants, vital for investors on NASDAQ.

Explore Cero Therapeutics' 8-K filing as of December 23, 2024, detailing common stock and warrant information, vital for investors and market analysts.